Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Alira Health, a global advisory and clinical research firm with the mission to humanize healthcare and life sciences, announces a new collaboration agreement signed with GDMH – Gemelli Digital Medicine & Health, part of Fondazione Policlinico Agostino Gemelli IRCCS (FPG) and prime provider of turn-key solutions in digital medicine and health in Italy. The goal of this partnership is to develop innovative solutions in the fields of Digital Health, Real-World Evidence (RWE) and Market Access in the best interest of research and patients, while ensuring the highest standards of data quality and protection.
About Alira Health
Alira Health is a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health complements the expertise of its Pharma, Biotech, and MedTech clients with a full spectrum of services across their entire solutions lifecycle.
Learn more: www.alirahealth.com
About GDMH – Gemelli Digital Medicine & Health
Gemelli Digital Medicine & Health (GDMH), a company fully owned by Fondazione Policlinico Gemelli, is a prime integrator and provider of turn-key solutions in Digital Medicine and Health. First movers in the market with the profile of a large general hospital spin off we co-create together with the best players in the Digital Medicine scenario, deploy and manage advanced digital medical solutions worldwide with complete ethical, technical, and legal credentials.
Learn more: www.gdmh.it
Alira Health CEO Gabriele Brambilla Interviewed by Investment Reports
Alira Health’s Renee Willmon and MG Registry featured in new Rare Disease Article Series
The MedTech World Podcast: Interview with Gabriele Brambilla
The State of Market Access in Italy 2023
MGFA National Patient Conference 2023
Diversity in Clinical Trials: A Blog Series
How Can Clinical Trials be More Inclusive?
Subscribe to our newsletter for the latest news, events, and thought leadership